The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals

NeuroImage

Volumn 60, Issue 1, 2012, Pages 614-622

  Rose, Emma J ^a   Greene, Ciara ^a   Kelly, Sinead ^a   Morris, Derek W ^a   Robertson, Ian H ^a   Fahey, Ciara ^a   Jacobson, Sarah ^a   O'Doherty, John ^a   Newell, Fiona N ^a   McGrath, Jane ^a   Bokde, Arun ^a   Garavan, Hugh ^a   Frodl, Thomas ^a   Gill, Michael ^a   Corvin, Aiden P ^a   Donohoe, Gary ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

FMRI; Medial prefrontal cortex; Nitric oxide synthase 1; Schizophrenia; VBM

Indexed keywords

ADULT; ALLELE; ARTICLE; BRAIN FUNCTION; CAUDATE NUCLEUS; CONTROLLED STUDY; CUNEUS; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE FUNCTION; GENETIC RISK; GENOTYPE; GRAY MATTER; GRAY MATTER VOLUME; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; LINGUAL GYRUS; MALE; MIDDLE FRONTAL GYRUS; NITRIC OXIDE SYNTHASE 1 GENE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SPATIAL WORKING MEMORY TASK; STRUCTURAL MAGNETIC RESONANCE IMAGING; SUPERIOR FRONTAL GYRUS; SUPERIOR PARIETAL LOBULE; TASK PERFORMANCE; VENTROMEDIAL PREFRONTAL CORTEX; VOXEL BASED MORPHOMETRY; WORKING MEMORY;

ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; NITRIC OXIDE SYNTHASE TYPE I; ORGAN SIZE; PREFRONTAL CORTEX; YOUNG ADULT;

EID: 84856098035     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.12.054     Document Type: Article

References (69)

1. Akyol O., Zoroglu S.S., Armutcu F., Sahin S., Gurel A. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo 2004, 18:377-390.
2. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007, 38:95-113.
3. Ashburner J., Friston K.J. Voxel-based morphometry - the methods. Neuroimage 2000, 11:805-821.
4. Bassett D.S., Bullmore E.T., Meyer-Lindenberg A., Apud J.A., Weinberger D.R., Coppola R. Cognitive fitness of cost-efficient brain functional networks. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11747-11752.
5. Bernstein H.G., Bogerts B., Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizophr. Res. 2005, 78:69-86.
6. Boehning D., Snyder S.H. Novel neural modulators. Annu. Rev. Neurosci. 2003, 26:105-131.
7. Brenman J.E., Bredt D.S. Synaptic signaling by nitric oxide. Curr. Opin. Neurobiol. 1997, 7:374-378.
8. Brown G.C. Nitric oxide and neuronal death. Nitric Oxide 2010, 23:153-165.
9. Buckner R.L., Andrews-Hanna J.R., Schacter D.L. The brain's default network - anatomy, function, and relevance to disease. Year Cogn. Neurosci. 2008, 2008:1-38.
10. Buonocore F., Hill M.J., Campbell C.D., Oladimeji P.B., Jeffries A.R., Troakes C., Hortobagyi T., Williams B.P., Cooper J.D., Bray N.J. Effects of cis-regulatory variation differ across regions of the adult human brain. Hum. Mol. Genet. 2010, 19:4490-4496.
11. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M.G. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8:766-775.
12. Chiueh C.C. Neurobiology of NO and OH - basic research and clinical relevance. Neurobiology of NO- and -OH 1994, 279-281. C.C. Chiueh, D.L. Gilbert, C.A. Colton (Eds.).
13. Chiueh C.C. Neuroprotective properties of nitric oxide. Neuroprotective Agents: Fourth International Conference 1999, 301-311. B. Trembly, W. Slikker (Eds.).
14. Corfield D.R., Murphy K., Josephs O., Adams L., Turner R. Does hypercapnia-induced cerebral vasodilation modulate the hemodynamic response to neural activation?. Neuroimage 2001, 13:1207-1211.
15. Cox R.W. AFNI software for analysis and visualization of functional magnetic resonance neuroimages. Comput. Biomed. Res. 1996, 29:162-173.
16. Csernansky J.G. Neurodegeneration in schizophrenia: evidence from in vivo neuroimaging studies. Thescientificworldjournal 2007, 7:135-143.
17. DeLisi L.E., Shaw S.H., Crow T.J., Shields G., Smith A.B., Larach V.W., Wellman N., Loftus J., Nanthakumar B., Razi K., Stewart J., Comazzi M., Vita A., Heffner T., Sherrington R. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am. J. Psychiatry 2002, 159:803-812.
18. Donohoe G., Walters J., Morris D.W., Quinn E.M., Judge R., Norton N., Giegling I., Hartmann A.M., Moller H.J., Muglia P., Williams H., Moskvina V., Peel R., O'Donoghue T., Owen M.J., O'Donovan M.C., Gill M., Rujescu D., Corvin A. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. Arch. Gen. Psychiatry 2009, 66:1045-1054.
19. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., Steel G., Nestadt G., Liang K.Y., Huganir R.L., Valle D., Pulver A.E. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am. J. Hum. Genet. 2005, 77:918-936.
20. Fox M.D., Snyder A.Z., Vincent J.L., Corbetta M., Van Essen D.C., Raichle M.E. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc. Natl. Acad. Sci. 2005, 102:9673-9678.
21. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988, 336:385-388.
22. Getting S.J., Segieth J., Ahmad S., Biggs C.S., Whitton P.S. Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo. Brain Res. 1996, 717:196-199.
23. Gusnard D.A., Akbudak E., Shulman G.L., Raichle M.E. Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4259-4264.
24. Hall A.V., Antoniou H., Wang Y., Cheung A.H., Arbus A.M., Olson S.L., Lu W.C., Kau C.L., Marsden P.A. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J. Biol. Chem. 1994, 269:33082-33090.
25. Hayasaka S., Phan K.L., Liberzon I., Worsley K.J., Nichols T.E. Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 2004, 22:676-687.
26. Joel D., Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 2000, 96:451-474.
27. Johansson C., Jackson D.M., Svensson L. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology (Berl.) 1997, 131:167-173.
28. Johansson C., Magnusson O., Deveney A.M., Jackson D.M., Zhang J.H., Engel J.A., Svensson L. The nitric oxide synthase inhibitor, l-NAME, blocks certain phencyclidine-induced but not amphetamine-induced effects on behaviour and brain biochemistry in the rat. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998, 22:1341-1360.
29. Kaehler S.T., Singewald N., Sinner C., Philippu A. Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Res. 1999, 835:346-349.
30. Kawada R., Yoshizumi M., Hirao K., Fujiwara H., Miyata J., Shimizu M., Namiki C., Sawamoto N., Fukuyama H., Hayashi T., Murai T. Brain volume and dysexecutive behavior in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1255-1260.
31. Khaldi A., Chiueh C.C., Bullock M.R., Woodward J.J. The significance of nitric oxide production in the brain after injury. Ann. N. Y. Acad. Sci. 2002, 962:53-59.
32. Kirchner L., Weitzdoerfer R., Hoeger H., Url A., Schmidt P., Engelmann M., Villar S.R., Fountoulakis M., Lubec G., Lubec B. Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements. Nitric Oxide 2004, 11:316-330.
33. Klamer D., Engel J.A., Svensson L. The nitric oxide synthase inhibitor, l-NAME, block phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology (Berl) 2001, 156:182-186.
34. Klamer D., Engel J.A., Svensson L. The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-l-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. Eur. J. Pharmacol. 2004, 503:103-107.
35. Klamer D., Palsson E., Revesz A., Engel J.A., Svensson L. Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms. Psychopharmacology (Berl) 2004, 176:440-450.
36. Klamer D., Engel J.A., Svensson L. Effects of phencyclidine on acoustic startle and prepulse inhibition in neuronal nitric oxide synthase deficient mice. Eur. Neuropsychopharmacol. 2005, 15:587-590.
37. Kopf J., Schecklmann M., Hahn T., Dresler T., Dieler A.C., Herrmann M.J., Fallgatter A.J., Reif A. NOS1 ex1f-VNTR polymorphism influences prefrontal brain oxygenation during a working memory task. Neuroimage 2011, 57:1617-1623.
38. Kopf, J., Schecklmann, M., Hahn, T., Dieler, A.C., Herrmann, M.J., Fallgatter, A.J., Reif, A., in press. NOS1 ex1f-VNTR polymorphism affects prefrontal oxygenation during response inhibition tasks. Hum. Brain Mapp.
39. Li C.Q., Wogan G.N. Nitric oxide as a modulator of apoptosis. Cancer Lett. 2005, 226:1-15.
40. Liou Y.J., Tsai S.J., Hong C.J., Liao D.L. Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia. Schizophr. Res. 2003, 65:57-59.
41. Lonart G., Wang J., Johnson K.M. Nitric oxide induces neurotransmitter release from hippocampal slices. Eur. J. Pharmacol. 1992, 220:271-272.
42. Lorrain D.S., Hull E.M. Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport 1993, 5:87-89.
43. Luciano M., Houlihan L.M., Harris S.E., Gow A.J., Hayward C., Starr J.M., Deary I.J. Association of existing and new candidate genes for anxiety, depression and personality traits in older people. Behav. Genet. 2010, 40:518-532.
44. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fmri data sets. Neuroimage 2003, 19:1233-1239. (WFU Pickatlas, version 2.4).
45. McKiernan K.A., Kaufman J.N., Kucera-Thompson J., Binder J.R. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J. Cogn. Neurosci. 2003, 15:394-408.
46. Nicodemus K.K., Law A.J., Radulescu E., Luna A., Kolachana B., Vakkalanka R., Rujescu D., Giegling I., Straub R.E., McGee K., Gold B., Dean M., Muglia P., Callicott J.H., Tan H.Y., Weinberger D.R. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch. Gen. Psychiatry 2010, 67:991-1001.
47. O'Donoghue, T., Morris, D.W., Fahey, C., Costa, A.D., Foxe, J.J., Hoerold, D., Tropea, D., Gill, M., Corvin, A., Donohoe, G., in press. A NOS1 variant implicated in cognitive performance influences evoked neural responses during a high density EEG study of early visual perception. Hum. Brain Mapp.
48. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C.A., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y.Y., Feng G.Y., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Mol Genetics Of Schizophrenia C. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40:1053-1055.
49. Ohkuma S., Katsura M., Chen D.Z., Narihara H., Kuriyama K. Nitric oxide-evoked [3H] gamma-aminobutyric acid release is mediated by two distinct release mechanisms. Brain Res. Mol. Brain Res. 1996, 36:137-144.
50. Palsson E., Fejgin K., Wass C., Engel J.A., Svensson L., Klamer D. The amino acid l-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice. Psychopharmacology (Berl) 2007, 192:9-15.
51. Pepicelli O., Raiteri M., Fedele E. The NOS/sGC pathway in the rat central nervous system: a microdialysis overview. Neurochem. Int. 2004, 45:787-797.
52. Pluta R.M., Rak R., Wink D.A., Woodward J.J., Khaldi A., Oldfield E.H., Watson J.C. Effects of nitric oxide on reactive oxygen species production and infarction size after brain reperfusion injury. Neurosurgery 2001, 48:884-892.
53. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:676-682.
54. Reif A., Herterich S., Strobel A., Ehlis A.C., Saur D., Jacob C.P., Wienker T., Topner T., Fritzen S., Walter U., Schmitt A., Fallgatter A.J., Lesch K.P. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol. Psychiatry 2006, 11:286-300.
55. Reif A., Jacob C.P., Rujescu D., Herterich S., Lang S., Gutknecht L., Baehne C.G., Strobel A., Freitag C.M., Giegling I., Romanos M., Hartmann A., Rosler M., Renner T.J., Fallgatter A.J., Retz W., Ehlis A.C., Lesch K.P. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch. Gen. Psychiatry 2009, 66:41-50.
56. Reif A., Kiive E., Kurrikoff T., Paaver M., Herterich S., Konstabel K., Tulviste T., Lesch K.P., Harro J. A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity. Psychopharmacology (Berl) 2010.
57. Reif A., Schecklmann M., Eirich E., Jacob C.P., Jarczok T.A., Kittel-Schneider S., Lesch K.P., Fallgatter A.J., Ehlis A.C. A functional promoter polymorphism of neuronal nitric oxide synthase moderates prefrontal functioning in schizophrenia. Int. J. Neuropsychopharmacol. 2011, 14:887-897.
58. Shinkai T., Ohmori O., Hori H., Nakamura J. Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol. Psychiatry 2002, 7:560-563.
59. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Borglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Bottcher Y., Olesen J., Breuer R., Moller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Rethelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
60. Talairach J., Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain 1988, Thieme, New York.
61. Tan H.Y., Callicott J.H., Weinberger D.R. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb. Cortex 2007, 17(Suppl 1):i171-i181.
62. Tang W., Huang K., Tang R., Zhou G., Fang C., Zhang J., Du L., Feng G., He L., Shi Y. Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population. Int. J. Neuropsychopharmacol. 2008, 11:1063-1071.
63. Toda N., Ayajiki K., Okamura T. Cerebral blood flow regulation by nitric oxide in neurological disorders. Can. J. Physiol. Pharmacol. 2009, 87:581-594.
64. Toda N., Ayajiki K., Okamura T. Control of systemic and pulmonary blood pressure by nitric oxide formed through neuronal nitric oxide synthase. J. Hypertens. 2009, 27:1929-1940.
65. Toro R., Fox P.T., Paus T. Functional coactivation map of the human brain. Cereb. Cortex 2008, 18:2553-2559.
66. Wass C., Archer T., Palsson E., Fejgin K., Klamer D., Engel J.A., Svensson L. Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent mechanisms. Behav. Brain Res. 2006, 171:147-153.
67. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
68. Weitzdoerfer R., Hoeger H., Engidawork E., Engelmann M., Singewald N., Lubec G., Lubec B. Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance. Nitric Oxide 2004, 10:130-140.
69. Worsley K.J., Andermann M., Koulis T., MacDonald D., Evans A.C. Detecting changes in nonisotropic images. Hum. Brain Mapp. 1999, 8:98-101.